New-onset diabetes and glucose regulation are significant determinants of left ventricular hypertrophy in renal transplant recipients.
Siren SezerMehtap Erkmen UyarEmre TutalZeynep BalOrhan GuliyevTuran ColakEfe HasdemirMehmet HaberalPublished in: Journal of diabetes research (2015)
HbA1c is the major determinant of LVMI, so strict control of serum glucose levels is essential for preventing cardiovascular disease in patients with NODAT.